Synopsis of recent research by authors named "Hadir A ElMahallawy"
- Hadir A ElMahallawy's research focuses on addressing antimicrobial resistance within oncology settings, particularly examining the prevalence and impact of multidrug-resistant infections such as Pseudomonas aeruginosa and various Candida species among cancer patients in Egypt.
- Recent studies reveal alarming trends of drug resistance, including increasing rates of azole-resistant Candida causing bloodstream infections and colistin resistance among Enterobacteriaceae, prompting the need for alternative treatment options and improved diagnostic techniques.
- ElMahallawy advocates for rapid molecular diagnostics to enhance timely and targeted antimicrobial therapy, which is crucial for improved hospital outcomes, especially in pediatric cancer patients presenting with sepsis.
